Trial · NCT03009110
Outcomes15
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 15 of 15
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Number of Participants With Superficial or Deep Surgical Site Infections (SSIs) | 30 days postoperatively | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Number of Participants With Superficial, Deep or Organ Space SSIs (Individual Types of SSIs) | 30 days postoperatively | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Number of Participants With Organ Space SSIs (Endometritis, Intraabdominal Abscess) | 30 days postoperatively | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Number of Participants With Wound Hematoma, Seroma, Separation (Other Wound Complications) | 30 days postoperatively | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Number of Participants With a Composite of Any Wound Complication Including SSI, Hematoma, Seroma, Separation (2cm or More). | 30 days postoperatively | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Patient Pain Score | At discharge, an average of 4 days postoperatively | score on a scale | MEDIAN | |
| SECONDARY | Patient Pain Score | At postoperative day 30 | score on a scale | MEDIAN | |
| SECONDARY | Patient Satisfaction Score | At discharge, an average of 4 days postoperatively | score on a scale | MEDIAN | |
| SECONDARY | Patient Satisfaction Score | At postoperative day 30 | score on a scale | MEDIAN | |
| SECONDARY | Number of Participants With Physician Office Visit, Emergency Room Visit, Attendance at Wound Clinic, Use Antibiotics, Hospital Readmission for Wound Related Problems (Measures of Healthcare Resource Utilization) | 30 days postoperatively | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Number of Participants With Skin Blistering, Erythema, Wound Bleeding (Measures of Adverse Skin Events) | 30 days postoperatively | Participants | COUNT_OF_PARTICIPANTS | |
| OTHER_PRE_SPECIFIED | Types and Frequency of Different Bacteria Including Methicillin-resistant Staphylococcus Aureus | 30 days postoperatively | |||
| OTHER_PRE_SPECIFIED | Incremental Cost Per SSI Prevented | 30 days postoperatively | |||
| OTHER_PRE_SPECIFIED | Incremental Cost Per Quality-Adjusted Life-year | 30 days postoperatively | |||
| OTHER_PRE_SPECIFIED | Risk Factors for Surgical Site Infections in Obese Women | 30 days postoperatively |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03009110/outcomes